Risultati di ricerca
5 giorni fa · U.S. Republican presidential nominee Mitt Romney (left) and U.S. President Barack Obama speak at the same time as moderator Bob Schieffer (centre) listens during the final U.S. presidential...
137 likes, 0 comments - tcuschieffer on June 28, 2024: "Did you catch the debate last night? Our namesake, Bob Schieffer '59 has moderated three presidential debates. Yesterday, he told Vanity Fair moderators should be "just trying to give people the best picture you can of who these candidates are." Learn more at the link in bio.
3 ore fa · Application Deadline: Open Until Filled. Application review will start on 7/15/24. Position Details: This full-time faculty position is on-campus and in-person. The Department of Communication Studies in the Bob Schieffer College of Communication at Texas Christian University (TCU) in Fort Worth, Texas invites applications for a Visiting Lecturer, specializing in public speaking, for the 2024 ...
1 giorno fa · Bob Schieffer of CBS The third presidential debate occurred on Wednesday, October 15 at 9:00 PM EST in the David S. Mack Sports and Exhibition Complex on the campus of Hofstra University . [69] The focus was on domestic policy and the economy.
18 ore fa · But, Cronkite and CBS News correspondent Bob Schieffer defended reports that the remark had been made. They said that members of Johnson's inner circle, who had watched the editorial with the president, including presidential aide George Christian and journalist Bill Moyers , later confirmed the accuracy of the quote to them.
3 giorni fa · CNN's Dana Bash asked Rep. Jim Clyburn about Joe Biden's (you knew this was coming) ability to lead the country following the debate between the President and the felon. Most of us were appalled to learn there would be no fact-checking during the debate.
5 giorni fa · Epcoritamab is a bispecific antibody. Like all bispecifics, it works in two parts. It attached itself to cancerous B cells (the way Rituxan works) but also attaches itself to a T cell, allowing that immune cell to work on the cancer cell. This will be the second bispecific available to at least some FL patients.
